22nd Century Group (NASDAQ:XXII) Earns Sell Rating from Analysts at StockNews.com

by · The Markets Daily

StockNews.com began coverage on shares of 22nd Century Group (NASDAQ:XXII – Free Report) in a research report sent to investors on Thursday morning. The firm issued a sell rating on the biotechnology company’s stock.

22nd Century Group Price Performance

Shares of XXII stock opened at $4.95 on Thursday. The company has a debt-to-equity ratio of 1.59, a current ratio of 1.09 and a quick ratio of 0.93. The company has a market capitalization of $1.70 million, a P/E ratio of -0.22 and a beta of 1.50. The company’s 50-day simple moving average is $12.73 and its two-hundred day simple moving average is $52.06. 22nd Century Group has a one year low of $3.90 and a one year high of $581.85.

22nd Century Group (NASDAQ:XXII – Get Free Report) last issued its quarterly earnings data on Tuesday, November 12th. The biotechnology company reported ($72.90) EPS for the quarter. The business had revenue of $5.95 million during the quarter. 22nd Century Group had a negative return on equity of 380.39% and a negative net margin of 144.09%.

Institutional Trading of 22nd Century Group

A hedge fund recently bought a new stake in 22nd Century Group stock. Anson Funds Management LP purchased a new stake in 22nd Century Group, Inc. (NASDAQ:XXII – Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,140,452 shares of the biotechnology company’s stock, valued at approximately $691,000. Anson Funds Management LP owned about 6.77% of 22nd Century Group as of its most recent filing with the Securities and Exchange Commission (SEC). 18.06% of the stock is owned by institutional investors.

About 22nd Century Group

(Get Free Report)

22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.

Featured Articles